{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:08Z","timestamp":1792757168589,"version":"4.5.0"},"reference-count":98,"publisher":"Bentham Science Publishers Ltd.","issue":"25","funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/ 200017"],"award-info":[{"award-number":["451-03-9\/2021-14\/ 200017"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Thyroid hormones (TH) have a significant impact on cellular oxidative metabolism. Besides that,\nthey maintain vascular homeostasis by positive effects on endothelial and vascular smooth muscle cells. Subclinical\n(SCH) and clinical (CH) hypothyroidism influences target organs by changing their morphology and\nfunction and impaired blood and oxygen supply induced by accelerated atherosclerosis. The increased risk of\nacceleration and extension of atherosclerosis in patients with SCH and CH could be explained by dyslipidemia,\ndiastolic hypertension, increased arterial stiffness, endothelial dysfunction, and altered blood coagulation. Instability\nof atherosclerotic plaque in hypothyroidism could cause excessive activity of the elements of innate\nimmunity, which are characterized by the significant presence of macrophages in atherosclerotic plaques, increased\nnuclear factor kappa B (NFkB) expression, and elevated levels of tumor necrosis factor \u03b1 (TNF-\u03b1) and\nmatrix metalloproteinase (MMP) 9, with reduced interstitial collagen; all of them together creates inflammation\nmilieu, resulting in plaque rupture. Optimal substitution by levothyroxine (LT4) restores biochemical euthyroidism.\nIn postmenopausal women and elderly patients with hypothyroidism and associated vascular\ncomorbidity, excessive LT4 substitution could lead to atrial rhythm disorders and osteoporosis. Therefore, it is\nof interest to maintain thyroid-stimulating hormone (TSH) levels in the reference range, thus eliminating the\ndeleterious effects of lower or higher TSH levels on the cardiovascular system. This review summarizes the recent\nliterature on subclinical and clinical hypothyroidism and atherosclerotic cardiovascular disease and discusses\nthe effects of LT4 replacement therapy on restoring biochemical euthyroidism and atherosclerosis processes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220620160516","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:44:23Z","timestamp":1655793863000},"page":"2065-2072","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Hypothyroidism and Risk of Cardiovascular Disease"],"prefix":"10.2174","volume":"28","author":[{"given":"Zoran M.","family":"Gluvic","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, Clinic for Internal Medicine, Zemun Clinical Hospital, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja S.","family":"Zafirovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, VIN\u010cA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan M.","family":"Obradovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, VIN\u010cA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina M.","family":"Sudar-Milovanovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, VIN\u010cA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Promise Department, School of Medicine,\nUniversity of Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[{"name":"Department of Radiobiology and Molecular Genetics, VIN\u010cA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1210\/rp.59.1.31","volume":"59","author":"Fazio S.","year":"2004","unstructured":"Fazio S.; Palmieri E.A.; Lombardi G.; Biondi B.; Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004,59,31-50","journal-title":"Recent Prog Horm Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.109.917922","volume":"122","author":"Gerdes A.M.","year":"2010","unstructured":"Gerdes A.M.; Iervasi G.; Thyroid replacement therapy and heart failure. Circulation 2010,122(4),385-393","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/CIRCULATIONAHA.105.572883","volume":"112","author":"Tang Y.D.","year":"2005","unstructured":"Tang Y.D.; Kuzman J.A.; Said S.; Anderson B.E.; Wang X.; Gerdes A.M.; Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 2005,112(20),3122-3130","journal-title":"Circulation"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","volume":"71","author":"Razvi S.","year":"2018","unstructured":"Razvi S.; Jabbar A.; Pingitore A.; Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol 2018,71(16),1781-1796","journal-title":"J Am Coll Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jacc.2004.10.044","volume":"45","author":"Ripoli A.","year":"2005","unstructured":"Ripoli A.; Pingitore A.; Favilli B.; Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 2005,45(3),439-445","journal-title":"J Am Coll Cardiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/105072502760143890","volume":"12","author":"Biondi B.","year":"2002","unstructured":"Biondi B.; Palmieri E.A.; Lombardi G.; Fazio S.; Subclinical hypothyroidism and cardiac function. Thyroid 2002,12(6),505-510","journal-title":"Thyroid"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/thy.2007.0158","volume":"17","author":"Biondi B.","year":"2007","unstructured":"Biondi B.; Cardiovascular effects of mild hypothyroidism. Thyroid 2007,17(7),625-630","journal-title":"Thyroid"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","volume":"363","author":"Roberts C.G.","year":"2004","unstructured":"Roberts C.G.; Ladenson P.W.; Hypothyroidism. Lancet 2004,363(9411),793-803","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0002-9149(03)00322-9","volume":"91","author":"Brenta G.","year":"2003","unstructured":"Brenta G.; Mutti L.A.; Schnitman M.; Fretes O.; Perrone A.; Matute M.L.; Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003,91(11),1327-1330","journal-title":"Am J Cardiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"Klein I.","year":"2001","unstructured":"Klein I.; Ojamaa K.; Thyroid hormone and the cardiovascular system. N Engl J Med 2001,344(7),501-509","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1213\/00000539-199710000-00005","volume":"85","author":"Park K.W.","year":"1997","unstructured":"Park K.W.; Dai H.B.; Ojamaa K.; Lowenstein E.; Klein I.; Sellke F.W.; The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg 1997,85(4),734-738","journal-title":"Anesth Analg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/thy.1996.6.505","volume":"6","author":"Ojamaa K.","year":"1996","unstructured":"Ojamaa K.; Klemperer J.D.; Klein I.; Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996,6(5),505-512","journal-title":"Thyroid"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJM199512073332302","volume":"333","author":"Klemperer J.D.","year":"1995","unstructured":"Klemperer J.D.; Klein I.; Gomez M.; Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995,333(23),1522-1527","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"Cooper D.S.","year":"2012","unstructured":"Cooper D.S.; Biondi B.; Subclinical thyroid disease. Lancet 2012,379(9821),1142-1154","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1001\/archinte.165.21.2460","volume":"165","author":"Rodondi N.","year":"2005","unstructured":"Rodondi N.; Newman A.B.; Vittinghoff E.; Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005,165(21),2460-2466","journal-title":"Arch Intern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"Rodondi N.","year":"2010","unstructured":"Rodondi N.; den Elzen W.P.; Bauer D.C.; Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010,304(12),1365-1374","journal-title":"JAMA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1210\/jc.2008-0167","volume":"93","author":"Razvi S.","year":"2008","unstructured":"Razvi S.; Shakoor A.; Vanderpump M.; Weaver J.U.; Pearce S.H.; The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis. J Clin Endocrinol Metab 2008,93(8),2998-3007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1210\/jc.2018-01604","volume":"104","author":"Einfeldt M.N.","year":"2019","unstructured":"Einfeldt M.N.; Olsen A.S.; Kristensen S.L.; Long-term outcome in patients with heart failure treated with levothyroxine: An observational nationwide cohort study. J Clin Endocrinol Metab 2019,104(5),1725-1734","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"Chaker L.","year":"2017","unstructured":"Chaker L.; Bianco A.C.; Jonklaas J.; Peeters R.P.; Hypothyroidism. Lancet 2017,390(10101),1550-1562","journal-title":"Lancet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5551\/jat.39917","volume":"24","author":"Aziz M.","year":"2017","unstructured":"Aziz M.; Kandimalla Y.; Machavarapu A.; Effect of thyroxin treatment on carotid intima-media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): A meta-analysis of clinical trials. J Atheroscler Thromb 2017,24(7),643-659","journal-title":"J Atheroscler Thromb"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1210\/jc.2003-030039","volume":"88","author":"Taddei S.","year":"2003","unstructured":"Taddei S.; Caraccio N.; Virdis A.; Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003,88(8),3731-3737","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","volume":"24","author":"Biondi B.","year":"2004","unstructured":"Biondi B.; Klein I.; Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004,24(1),1-13","journal-title":"Endocrine"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"95","author":"Flynn R.W.","year":"2010","unstructured":"Flynn R.W.; Bonellie S.R.; Jung R.T.; MacDonald T.M.; Morris A.D.; Leese G.P.; Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010,95(1),186-193","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.758043","volume":"12","author":"Gluvic Z.","year":"2021","unstructured":"Gluvic Z.; Obradovic M.; Stewart A.J.; Levothyroxine treatment and the risk of cardiac arrhythmias - focus on the patient submitted to thyroid surgery. Front Endocrinol (Lausanne) 2021,12","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-16-0462","volume":"232","author":"van der Spek A.H.","year":"2017","unstructured":"van der Spek A.H.; Fliers E.; Boelen A.; Thyroid hormone metabolism in innate immune cells. J Endocrinol 2017,232(2),R67-R81","journal-title":"J Endocrinol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.3390\/ijms21114140","volume":"21","author":"Giammanco M.","year":"2020","unstructured":"Giammanco M.; Di Liegro C.M.; Schiera G.; Di Liegro I.; Genomic and non-genomic mechanisms of action of thyroid hormones and their catabolite 3,5-Diiodo-L-Thyronine in mammals. Int J Mol Sci 2020,21(11),4140","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells9102155","volume":"9","author":"Forini F.","year":"2020","unstructured":"Forini F.; Nicolini G.; Kusmic C.; T3 critically affects the Mhrt\/Brg1 axis to regulate the cardiac MHC switch: Role of an epigenetic cross-talk. Cells 2020,9(10),9","journal-title":"Cells"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3390\/ijms20143377","volume":"20","author":"Forini F.","year":"2019","unstructured":"Forini F.; Nicolini G.; Kusmic C.; Iervasi G.; Protective effects of euthyroidism restoration on mitochondria function and quality control in cardiac pathophysiology. Int J Mol Sci 2019,20(14),3377","journal-title":"Int J Mol Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14797\/mdcj-13-2-55","volume":"13","author":"Udovcic M.","year":"2017","unstructured":"Udovcic M.; Pena R.H.; Patham B.; Tabatabai L.; Kansara A.; Hypothyroidism and the heart. Methodist DeBakey Cardiovasc J 2017,13(2),55-59","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrendo.2015.205","volume":"12","author":"Davis P.J.","year":"2016","unstructured":"Davis P.J.; Goglia F.; Leonard J.L.; Nongenomic actions of thyroid hormone. Nat Rev Endocrinol 2016,12(2),111-121","journal-title":"Nat Rev Endocrinol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.7860\/JCDR\/2013\/5777.3448","volume":"7","author":"Karthick N.","year":"2013","unstructured":"Karthick N.; Dillara K.; Poornima K.N.; Subhasini A.S.; Dyslipidaemic changes in women with subclinical hypothyroidism. J Clin Diagn Res 2013,7(10),2122-2125","journal-title":"J Clin Diagn Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1590\/S0004-27302011000700007","volume":"55","author":"Valentina V.N.","year":"2011","unstructured":"Valentina V.N.; Marijan B.; Chedo D.; Branka K.; Subclinical hypothyroidism and risk to carotid atherosclerosis. Arq Bras Endocrinol Metabol 2011,55(7),475-480","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131776","volume":"10","author":"Gao C.","year":"2015","unstructured":"Gao C.; Li T.; Liu J.; Guo Q.; Tian L.; Endothelial functioning and hemodynamic parameters in rats with subclinical hypothyroid and the effects of thyroxine replacement. PLoS One 2015,10(7)","journal-title":"PLoS One"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1570161114666160208143537","volume":"14","author":"Obradovic M.","year":"2016","unstructured":"Obradovic M.; Gluvic Z.; Sudar-Milovanovic E.; Nitric oxide as a marker for levo-thyroxine therapy in subclinical hypothyroid patients. Curr Vasc Pharmacol 2016,14(3),266-270","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","volume":"11","author":"Kannan L.","year":"2018","unstructured":"Kannan L.; Shaw P.A.; Morley M.P.; Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail 2018,11(12)","journal-title":"Circ Heart Fail"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"39207","DOI":"10.18632\/oncotarget.9393","volume":"7","author":"Dong J.","year":"2016","unstructured":"Dong J.; Gao C.; Liu J.; Cao Y.; Tian L.; TSH inhibits SERCA2a and the PKA\/PLN pathway in rat cardiomyocytes. Oncotarget 2016,7(26),39207-39215","journal-title":"Oncotarget"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8682765","volume":"2018","author":"Chen X.","year":"2018","unstructured":"Chen X.; Gao C.; Gong N.; Wang Y.; Tian L.; The change of left ventricular function in rats with subclinical hypothyroid and the effects of thyroxine replacement. Int J Endocrinol 2018,2018","journal-title":"Int J Endocrinol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EC-18-0007","volume":"7","author":"Gong N.","year":"2018","unstructured":"Gong N.; Gao C.; Chen X.; Wang Y.; Tian L.; Adipokine expression and endothelial function in subclinical hypothyroidism rats. Endocr Connect 2018,7(2),295-304","journal-title":"Endocr Connect"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12872-020-01646-3","volume":"20","author":"Xue D.","year":"2020","unstructured":"Xue D.; Sun J.L.; Yang J.; Early L-T4 intervention improves fetal heart development in pregnant rats with subclinical hypothyroidism rats by activating BMP4\/Smad4 signaling pathway. BMC Cardiovasc Disord 2020,20(1),369","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1365-2265.1977.tb01341.x","volume":"7","author":"Tunbridge W.M.","year":"1977","unstructured":"Tunbridge W.M.; Evered D.C.; Hall R.; Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977,7(6),495-508","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=41","first-page":"155","volume":"6","author":"Vanderpump M.P.","year":"1996","unstructured":"Vanderpump M.P.; Tunbridge W.M.; French J.M.; The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996,6(3),155-160","journal-title":"Thyroid"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"Hak A.E.","year":"2000","unstructured":"Hak A.E.; Pols H.A.; Visser T.J.; Drexhage H.A.; Hofman A.; Witteman J.C.; Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The rotterdam study. Ann Intern Med 2000,132(4),270-278","journal-title":"Ann Intern Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0002-9343(92)90782-7","volume":"92","author":"Staub J.J.","year":"1992","unstructured":"Staub J.J.; Althaus B.U.; Engler H.; Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992,92(6),631-642","journal-title":"Am J Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(72)90534-X","volume":"1","author":"Heinonen O.P.","year":"1972","unstructured":"Heinonen O.P.; Gordin A.; Aho K.; Punsar S.; Py\u00f6r\u00e4l\u00e4 K.; Puro K.; Symptomless autoimmune thyroiditis in coronary heart-disease. Lancet 1972,1(7754),785-786","journal-title":"Lancet"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1210\/jc.2003-031089","volume":"89","author":"Imaizumi M.","year":"2004","unstructured":"Imaizumi M.; Akahoshi M.; Ichimaru S.; Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004,89(7),3365-3370","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","volume":"26","author":"Biondi B.","year":"2012","unstructured":"Biondi B.; Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract Res Clin Endocrinol Metab 2012,26(4),431-446","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/archinte.168.8.855","volume":"168","author":"Asvold B.O.","year":"2008","unstructured":"Asvold B.O.; Bj\u00f8ro T.; Nilsen T.I.; Gunnell D.; Vatten L.J.; Thyrotropin levels and risk of fatal coronary heart disease: The HUNT study. Arch Intern Med 2008,168(8),855-860","journal-title":"Arch Intern Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1001\/archinte.165.21.2467","volume":"165","author":"Walsh J.P.","year":"2005","unstructured":"Walsh J.P.; Bremner A.P.; Bulsara M.K.; Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005,165(21),2467-2472","journal-title":"Arch Intern Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2265.2009.03640.x","volume":"72","author":"Boekholdt S.M.","year":"2010","unstructured":"Boekholdt S.M.; Titan S.M.; Wiersinga W.M.; Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 2010,72(3),404-410","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9343(97)89462-4","volume":"100","author":"Surks M.I.","year":"1996","unstructured":"Surks M.I.; Ocampo E.; Subclinical thyroid disease. Am J Med 1996,100(2),217-223","journal-title":"Am J Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","volume":"87","author":"Caraccio N.","year":"2002","unstructured":"Caraccio N.; Ferrannini E.; Monzani F.; Lipoprotein profile in subclinical hypothyroidism: Response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002,87(4),1533-1538","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/thy.2000.10.803","volume":"10","author":"Tzotzas T.","year":"2000","unstructured":"Tzotzas T.; Krassas G.E.; Konstantinidis T.; Bougoulia M.; Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 2000,10(9),803-808","journal-title":"Thyroid"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/10507250050137743","volume":"10","author":"Kahaly G.J.","year":"2000","unstructured":"Kahaly G.J.; Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000,10(8),665-679","journal-title":"Thyroid"},{"key":"ref=54","first-page":"2993","volume":"85","author":"Danese M.D.","year":"2000","unstructured":"Danese M.D.; Ladenson P.W.; Meinert C.L.; Powe N.R.; Clinical review 115: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature. J Clin Endocrinol Metab 2000,85(9),2993-3001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2265.1993.tb02366.x","volume":"39","author":"Geul K.W.","year":"1993","unstructured":"Geul K.W.; van Sluisveld I.L.; Grobbee D.E.; The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: Associations with serum lipids. Clin Endocrinol 1993,39(3),275-280","journal-title":"Clin Endocrinol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2265.1992.tb02351.x","volume":"37","author":"Parle J.V.","year":"1992","unstructured":"Parle J.V.; Franklyn J.A.; Cross K.W.; Jones S.R.; Sheppard M.C.; Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol 1992,37(5),411-414","journal-title":"Clin Endocrinol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2265.1995.tb02616.x","volume":"43","author":"Kung A.W.","year":"1995","unstructured":"Kung A.W.; Pang R.W.; Janus E.D.; Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol 1995,43(4),445-449","journal-title":"Clin Endocrinol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1507\/endocrj.43.731","volume":"43","author":"Yildirimkaya M.","year":"1996","unstructured":"Yildirimkaya M.; Ozata M.; Yilmaz K.; Kilin\u00e7 C.; G\u00fcndo\u011fan M.A.; Kutluay T.; Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 1996,43(6),731-736","journal-title":"Endocr J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1210\/jc.2003-031669","volume":"89","author":"Monzani F.","year":"2004","unstructured":"Monzani F.; Caraccio N.; Koz\u00e0kow\u00e0 M.; Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: A double-blind, placebo- controlled study. J Clin Endocrinol Metab 2004,89(5),2099-2106","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0026-0495(95)90075-6","volume":"44","author":"Arem R.","year":"1995","unstructured":"Arem R.; Escalante D.A.; Arem N.; Morrisett J.D.; Patsch W.; Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism 1995,44(12),1559-1563","journal-title":"Metabolism"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1210\/jcem.86.10.7973","volume":"86","author":"Meier C.","year":"2001","unstructured":"Meier C.; Staub J.J.; Roth C.B.; TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: A double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001,86(10),4860-4866","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=62","first-page":"562","volume":"80","author":"Pazos F.","year":"1995","unstructured":"Pazos F.; Alvarez J.J.; Rubi\u00e9s-Prat J.; Varela C.; Lasunci\u00f3n M.A.; Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 1995,80(2),562-566","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1210\/jc.2010-1382","volume":"96","author":"Marfella R.","year":"2011","unstructured":"Marfella R.; Ferraraccio F.; Rizzo M.R.; Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. J Clin Endocrinol Metab 2011,96(4),1015-1020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1161\/01.CIR.0000050626.25057.51","volume":"107","author":"Salonen R.M.","year":"2003","unstructured":"Salonen R.M.; Nyyss\u00f6nen K.; Kaikkonen J.; Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003,107(7),947-953","journal-title":"Circulation"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0015-0282(02)04580-6","volume":"79","author":"Erenus M.","year":"2003","unstructured":"Erenus M.; Ilhan A.H.; Elter K.; Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries. Fertil Steril 2003,79(2),268-273","journal-title":"Fertil Steril"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/147070","volume":"2015","author":"Gluvic Z.","year":"2015","unstructured":"Gluvic Z.; Sudar E.; Tica J.; Effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: A prospective pilot study. Int J Endocrinol 2015,2015","journal-title":"Int J Endocrinol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/01.RES.88.3.313","volume":"88","author":"Mizuma H.","year":"2001","unstructured":"Mizuma H.; Murakami M.; Mori M.; Thyroid hormone activation in human vascular smooth muscle cells: Expression of type II iodothyronine deiodinase. Circ Res 2001,88(3),313-318","journal-title":"Circ Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/01.CIR.0000105767.94169.E3","volume":"109","author":"Weber T.","year":"2004","unstructured":"Weber T.; Auer J.; O\u2019Rourke M.F.; Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004,109(2),184-189","journal-title":"Circulation"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10741-008-9126-6","volume":"15","author":"Galli E.","year":"2010","unstructured":"Galli E.; Pingitore A.; Iervasi G.; The role of thyroid hormone in the pathophysiology of heart failure: Clinical evidence. Heart Fail Rev 2010,15(2),155-169","journal-title":"Heart Fail Rev"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrendo.2010.105","volume":"6","author":"Biondi B.","year":"2010","unstructured":"Biondi B.; Kahaly G.J.; Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 2010,6(8),431-443","journal-title":"Nat Rev Endocrinol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1210\/jc.2003-030398","volume":"88","author":"Cappola A.R.","year":"2003","unstructured":"Cappola A.R.; Ladenson P.W.; Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003,88(6),2438-2444","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fphys.2020.00729","volume":"11","author":"Wang K.","year":"2020","unstructured":"Wang K.; Ojamaa K.; Samuels A.; BNP as a new biomarker of cardiac thyroid hormone function. Front Physiol 2020,11,729","journal-title":"Front Physiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.36740\/WLek202010119","volume":"73","author":"Chuhray S.N.","year":"2020","unstructured":"Chuhray S.N.; Lavrynenko V.E.; Kaminsky R.F.; Cardiovascular system of the mature rats with congenital hypothyroidism and arterial hypertension. Wiad Lek 2020,73(10),2209-2213","journal-title":"Wiad Lek"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00210-020-01812-6","volume":"393","author":"Ghanbari M.","year":"2020","unstructured":"Ghanbari M.; Norouzirad R.; Bagheripuor F.; Jeddi S.; Ghasemi A.; Changes in nitric oxide synthase levels are associated with impaired cardiac function and tolerance to ischemia-reperfusion injury in male rats with transient congenital hypothyroidism. Naunyn Schmiedebergs Arch Pharmacol 2020,393(6),1103-1111","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1210\/jcem.85.5.6520","volume":"85","author":"Bengel F.M.","year":"2000","unstructured":"Bengel F.M.; Nekolla S.G.; Ibrahim T.; Weniger C.; Ziegler S.I.; Schwaiger M.; Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 2000,85(5),1822-1827","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0140-6736(67)92235-0","volume":"2","author":"Vanhaelst L.","year":"1967","unstructured":"Vanhaelst L.; Neve P.; Chailly P.; Bastenie P.A.; Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 1967,2(7520),800-802","journal-title":"Lancet"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-68-2-338","volume":"68","author":"Steinberg A.D.","year":"1968","unstructured":"Steinberg A.D.; Myxedema and coronary artery disease--a comparative autopsy study. Ann Intern Med 1968,68(2),338-344","journal-title":"Ann Intern Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"Jabbar A.","year":"2017","unstructured":"Jabbar A.; Pingitore A.; Pearce S.H.; Zaman A.; Iervasi G.; Razvi S.; Thyroid hormones and cardiovascular disease. Nat Rev Cardiol 2017,14(1),39-55","journal-title":"Nat Rev Cardiol"},{"key":"ref=79","first-page":"217","volume":"29","author":"Walton K.W.","year":"1965","unstructured":"Walton K.W.; Scott P.J.; Dykes P.W.; Davies J.W.; The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci 1965,29(2),217-238","journal-title":"Clin Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1042\/bj2760825","volume":"276","author":"Salter A.M.","year":"1991","unstructured":"Salter A.M.; Hayashi R.; al-Seeni M.; Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver. Biochem J 1991,276(Pt 3),825-832","journal-title":"Biochem J"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1210\/endo-127-3-1144","volume":"127","author":"Staels B.","year":"1990","unstructured":"Staels B.; Van Tol A.; Chan L.; Will H.; Verhoeven G.; Auwerx J.; Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 1990,127(3),1144-1152","journal-title":"Endocrinology"},{"key":"ref=82","first-page":"3421","volume":"82","author":"Sundaram V.","year":"1997","unstructured":"Sundaram V.; Hanna A.N.; Koneru L.; Newman H.A.; Falko J.M.; Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 1997,82(10),3421-3424","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1210\/jcem.83.5.4759","volume":"83","author":"Diekman T.","year":"1998","unstructured":"Diekman T.; Demacker P.N.; Kastelein J.J.; Stalenhoef A.F.; Wiersinga W.M.; Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 1998,83(5),1752-1755","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0261-5614(98)80031-9","volume":"18","author":"Becerra A.","year":"1999","unstructured":"Becerra A.; Bellido D.; Luengo A.; Pi\u00e9drola G.; De Luis D.A.; Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clin Nutr 1999,18(5),319-322","journal-title":"Clin Nutr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1210\/jcem.84.7.5812","volume":"84","author":"Weintraub M.","year":"1999","unstructured":"Weintraub M.; Grosskopf I.; Trostanesky Y.; Charach G.; Rubinstein A.; Stern N.; Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism. J Clin Endocrinol Metab 1999,84(7),2532-2536","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=86","first-page":"797","volume":"81","author":"Ritter M.C.","year":"1996","unstructured":"Ritter M.C.; Kannan C.R.; Bagdade J.D.; The effects of hypothyroidism and replacement therapy on cholesteryl ester transfer. J Clin Endocrinol Metab 1996,81(2),797-800","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=87","first-page":"513","volume":"59","author":"Lam K.S.","year":"1986","unstructured":"Lam K.S.; Chan M.K.; Yeung R.T.; High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment. Q J Med 1986,59(229),513-521","journal-title":"Q J Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1056\/NEJM199510123331503","volume":"333","author":"M\u00fcller B.","year":"1995","unstructured":"M\u00fcller B.; Zulewski H.; Huber P.; Ratcliffe J.G.; Staub J.J.; Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995,333(15),964-969","journal-title":"N Engl J Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"l4892","DOI":"10.1136\/bmj.l4892","volume":"366","author":"Thayakaran R.","year":"2019","unstructured":"Thayakaran R.; Adderley N.J.; Sainsbury C.; Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: Longitudinal study. BMJ 2019,366,l4892","journal-title":"BMJ"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"Bonetti P.O.","year":"2003","unstructured":"Bonetti P.O.; Lerman L.O.; Lerman A.; Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003,23(2),168-175","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphys.2017.00225","volume":"8","author":"Rajagopalan V.","year":"2017","unstructured":"Rajagopalan V.; Zhang Y.; Pol C.; Modified low-dose triiodo-l-thyronine therapy safely improves function following myocardial ischemia-reperfusion injury. Front Physiol 2017,8,225","journal-title":"Front Physiol"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151413","volume":"11","author":"Rajagopalan V.","year":"2016","unstructured":"Rajagopalan V.; Zhang Y.; Ojamaa K.; Safe oral triiodo-L-thyronine therapy protects from post-infarct cardiac dysfunction and arrhythmias without cardiovascular adverse effects. PLoS One 2016,11(3)","journal-title":"PLoS One"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2006-1869","volume":"92","author":"Razvi S.","year":"2007","unstructured":"Razvi S.; Ingoe L.; Keeka G.; Oates C.; McMillan C.; Weaver J.U.; The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial. J Clin Endocrinol Metab 2007,92(5),1715-1723","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/01.CIR.0000012543.55874.47","volume":"105","author":"Gokce N.","year":"2002","unstructured":"Gokce N.; Keaney J.F.; Hunter L.M.; Watkins M.T.; Menzoian J.O.; Vita J.A.; \n\n\n\n Circulation 2002,105(13),1567-1572","journal-title":"Circulation"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1113\/jphysiol.2005.089755","volume":"568","author":"Pyke K.E.","year":"2005","unstructured":"Pyke K.E.; Tschakovsky M.E.; The relationship between shear stress and flow-mediated dilatation: Implications for the assessment of endothelial function. J Physiol 2005,568(Pt 2),357-369","journal-title":"J Physiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"518","DOI":"10.7326\/0003-4819-124-5-199603010-00013","volume":"124","author":"Garber A.M.","year":"1996","unstructured":"Garber A.M.; Browner W.S.; Hulley S.B.; Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med 1996,124(5),518-531","journal-title":"Ann Intern Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/00004872-199816070-00008","volume":"16","author":"Zanchetti A.","year":"1998","unstructured":"Zanchetti A.; Bond M.G.; Hennig M.; Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European lacidipine study on atherosclerosis. J Hypertens 1998,16(7),949-961","journal-title":"J Hypertens"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","volume":"166","author":"Christ-Crain M.","year":"2003","unstructured":"Christ-Crain M.; Meier C.; Guglielmetti M.; Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 2003,166(2),379-386","journal-title":"Atherosclerosis"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220620160516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206223\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220620160516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T17:03:00Z","timestamp":1691686980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206223\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":98,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220620160516","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}